Revealing on April 30: Are You Ready for the Upcoming Election Surprise?
Here is the latest financial fact sheet of WOCKHARDT. For more details, see the WOCKHARDT quarterly results and WOCKHARDT share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.5 |
No. of shares | m | 153.40 |
1 Week | % | -0.6 |
1 Month | % | 7.7 |
1 Year | % | 235.5 |
52 week H/L | Rs | 630.0/165.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
WOCKHARDT EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 853 | 471 | 570 | 805 | 316 | |
Low | Rs | 375 | 147 | 174 | 253 | 145 | |
Sales per share (Unadj.) | Rs | 322.1 | 256.8 | 244.4 | 224.2 | 184.0 | |
Earnings per share (Unadj.) | Rs | -28.2 | -12.5 | -26.8 | -19.4 | -43.1 | |
Diluted earnings per share | Rs | -20.3 | -9.0 | -19.4 | -18.2 | -40.5 | |
Cash flow per share (Unadj.) | Rs | -13.4 | 7.8 | -4.6 | -2.2 | -25.7 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 238.7 | 238.5 | 302.2 | 265.9 | 231.7 | |
Adj. book value per share | Rs | 172.3 | 172.2 | 218.3 | 249.7 | 217.6 | |
Shares outstanding (eoy) | m | 110.69 | 110.74 | 110.78 | 144.06 | 144.09 | |
Price / Sales ratio | x | 1.9 | 1.2 | 1.5 | 2.4 | 1.3 | |
Avg P/E ratio | x | -21.8 | -24.8 | -13.9 | -27.3 | -5.3 | |
P/CF ratio (eoy) | x | -46.0 | 39.7 | -80.8 | -238.1 | -9.0 | |
Price / Book Value ratio | x | 2.6 | 1.3 | 1.2 | 2.0 | 1.0 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 67,936 | 34,201 | 41,188 | 76,186 | 33,202 | |
Total wages/salary | Rs m | 8,004 | 7,433 | 7,630 | 7,490 | 6,370 |
WOCKHARDT INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 35,658 | 28,440 | 27,080 | 32,300 | 26,510 | |
Other income | Rs m | 210 | 601 | 1,320 | 200 | 1,220 | |
Total revenues | Rs m | 35,869 | 29,041 | 28,400 | 32,500 | 27,730 | |
Gross profit | Rs m | -385 | 978 | -2,050 | 1,150 | -1,930 | |
Depreciation | Rs m | 1,640 | 2,241 | 2,460 | 2,470 | 2,510 | |
Interest | Rs m | 2,651 | 2,757 | 2,490 | 2,990 | 3,020 | |
Profit before tax | Rs m | -4,466 | -3,420 | -5,680 | -4,110 | -6,240 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | -1,348 | -2,041 | -2,710 | -1,320 | -30 | |
Profit after tax | Rs m | -3,118 | -1,380 | -2,970 | -2,790 | -6,210 | |
Gross profit margin | % | -1.1 | 3.4 | -7.6 | 3.6 | -7.3 | |
Effective tax rate | % | 30.2 | 59.7 | 47.7 | 32.1 | 0.5 | |
Net profit margin | % | -8.7 | -4.9 | -11.0 | -8.6 | -23.4 |
WOCKHARDT BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 28,147 | 24,005 | 22,810 | 24,450 | 19,140 | |
Current liabilities | Rs m | 28,637 | 34,972 | 31,210 | 32,070 | 34,350 | |
Net working cap to sales | % | -1.4 | -38.6 | -31.0 | -23.6 | -57.4 | |
Current ratio | x | 1.0 | 0.7 | 0.7 | 0.8 | 0.6 | |
Inventory Days | Days | 26 | 30 | 31 | 31 | 39 | |
Debtors Days | Days | 13 | 16 | 12 | 10 | 11 | |
Net fixed assets | Rs m | 47,564 | 53,197 | 49,510 | 50,810 | 48,670 | |
Share capital | Rs m | 553 | 554 | 550 | 720 | 720 | |
"Free" reserves | Rs m | 25,872 | 25,863 | 32,930 | 37,590 | 32,660 | |
Net worth | Rs m | 26,425 | 26,417 | 33,480 | 38,310 | 33,380 | |
Long term debt | Rs m | 18,915 | 12,409 | 5,030 | 3,550 | 2,240 | |
Total assets | Rs m | 75,710 | 77,495 | 73,760 | 76,700 | 70,750 | |
Interest coverage | x | -0.7 | -0.2 | -1.3 | -0.4 | -1.1 | |
Debt to equity ratio | x | 0.7 | 0.5 | 0.2 | 0.1 | 0.1 | |
Sales to assets ratio | x | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | |
Return on assets | % | -0.6 | 1.8 | -0.7 | 0.3 | -4.5 | |
Return on equity | % | -11.8 | -5.2 | -8.9 | -7.3 | -18.6 | |
Return on capital | % | -4.0 | -1.7 | -8.3 | -2.7 | -9.0 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 7.5 | 3.6 | 1.8 | 1.9 | 3.5 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 2,678 | 1,027 | 498 | 624 | 920 | |
Fx inflow | Rs m | 6,262 | 4,981 | 1,009 | 2,263 | 730 | |
Fx outflow | Rs m | 2,678 | 1,027 | 498 | 624 | 920 | |
Net fx | Rs m | 3,584 | 3,954 | 511 | 1,638 | -190 |
WOCKHARDT CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 1,833 | 6,490 | -2,870 | 4,130 | 1,530 | |
From Investments | Rs m | 946 | -1,555 | 14,700 | -2,010 | -1,250 | |
From Financial Activity | Rs m | -7,765 | -6,796 | -11,710 | -710 | -3,150 | |
Net Cashflow | Rs m | -4,999 | -1,780 | 130 | 1,380 | -2,800 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Habil Khorakiwala | COMP SEC: Debashis Dey | YEAR OF INC: 1999 | BSE CODE: 532300 | FV (Rs): 5 | DIV YIELD (%): - |
Read: WOCKHARDT 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare WOCKHARDT With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.